⌘K

Login Start Free

Home/Filings/4/0001818382-23-000165

4//SEC Filing

Wallace Max N. 4

Accession 0001818382-23-000165

CIK 0001818382other

View on SEC.gov Company Profile

Filed

Nov 20, 7:00 PM ET

Accepted

Nov 21, 4:07 PM ET

Size

6.5 KB

Accession

0001818382-23-000165

Insider Transaction Report

Form 4

Period: 2023-11-21

Humacyte, Inc.HUMA

Director

Transactions

Exercise/Conversion
Stock Options (right to buy)
2023-11-21−6,564→ 0 total
Exercise: $1.19From: 2016-11-22Exp: 2023-11-22→ Common Stock (6,564 underlying)
Exercise/Conversion
Common Stock
2023-11-21$1.19/sh+6,564$7,811→ 56,550 total

Documents

1 file

4
wk-form4_1700600845.xmlPrimary
FORM 4

Issuer

Humacyte, Inc.

CIK 0001818382

Entity typeother

Related Parties

1

filerCIK 0001877453

Filing Metadata

Form type: 4
Filed: Nov 20, 7:00 PM ET
Accepted: Nov 21, 4:07 PM ET
Size: 6.5 KB

View on SEC.gov